Company Filing History:
Years Active: 2016
Title: Jang Mi Sun: Innovator in Pharmaceutical Composition for Atopic Dermatitis
Introduction
Jang Mi Sun is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of atopic dermatitis. His innovative work has led to the development of a unique pharmaceutical composition that utilizes natural extracts.
Latest Patents
Jang Mi Sun holds a patent for his invention titled "Daphne genkwa extracts, and pharmaceutical composition containing fractions of the extracts or compounds separated from the extracts as active ingredients for preventing or treating atopic dermatitis." This invention relates to a pharmaceutical composition that comprises extracts and compounds isolated from Daphne genkwa. The active ingredients are designed to increase the secretion of cytokines in Th1 immune cells, effectively suppressing atopy in mouse models. This advancement holds promise for the prevention and treatment of atopic dermatitis.
Career Highlights
Jang Mi Sun is affiliated with the Korea Research Institute of Bioscience and Biotechnology. His work at this esteemed institution has allowed him to focus on innovative research and development in the field of bioscience. His dedication to advancing pharmaceutical solutions has positioned him as a key figure in his area of expertise.
Collaborations
Jang Mi Sun collaborates with esteemed colleagues, including Jae Wha Kim and Kyung Seop Ahn. These partnerships enhance the research and development process, fostering an environment of innovation and discovery.
Conclusion
Jang Mi Sun's contributions to the field of pharmaceuticals, particularly in the treatment of atopic dermatitis, highlight his role as an influential inventor. His patent on Daphne genkwa extracts showcases the potential for natural compounds in medical applications. His ongoing work continues to inspire advancements in bioscience and biotechnology.